GlassScriptPhysician profile
Andrew Standerwick
NPI 1598961898
$3,740.62
in general payments reported to CMS, 2019-2025
21 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,065 · 2020: $476 · 2021: $96.28 · 2022: $109 · 2023: $311 · 2024: $480 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,822.68 | 2019-2025 | |
| Davol INC. | $415.52 | 2020 | |
| Ethicon US, LLC | $349.05 | 2019-2024 | Echelon Flex, Echelon; Endopath |
| Stryker Corporation | $319.32 | 2019-2023 | Spy-Phi System, 1788, Aim (Advanced Imaging Modality) |
| Aesculap, INC. | $127.89 | 2019 | |
| Haemonetics Corporation | $123.77 | 2023-2024 | Teg6s Hemostasis System |
| Allergan, INC. | $98.09 | 2019-2022 | |
| Medtronic, INC. | $93.27 | 2024 | Ligasure, Signia |
| Heron Therapeutics, INC. | $60.67 | 2022-2023 | Zynrelef |
| Kerecis Limited | $45.27 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Baudax Bio INC. | $40.65 | 2021 | |
| Baxter Healthcare | $39.82 | 2024 | Perclot |
| Olympus America INC. | $35.31 | 2019 | |
| Mimedx Group, INC. | $26.59 | 2025 | |
| Aroa Biosurgery Incorporated | $24.82 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $24.24 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $23.94 | 2024 | Exparel |
| Acera Surgical, INC. | $20.56 | 2025 | Restrata Wound Matrix |
| Acell, INC. | $20.00 | 2019 | |
| Endo Pharmaceuticals INC. | $19.32 | 2019 | |
| Alafair Biosciences, INC. | $9.84 | 2025 | Versawrap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Standerwick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.